Adalbert Healthcare Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 23-06-2024
- Paid Up Capital ₹ 0.10 M
as on 23-06-2024
- Company Age 9 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 8.00 M
as on 23-06-2024
- Revenue 6.31%
(FY 2023)
- Profit -12.78%
(FY 2023)
- Ebitda -13.71%
(FY 2023)
- Net Worth 9.82%
(FY 2023)
- Total Assets -1.04%
(FY 2023)
About Adalbert Healthcare
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company has closed loans amounting to ₹8.00 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Sabita Kumari and Navin Kumar serve as directors at the Company.
- CIN/LLPIN
U51502MH2015PTC263321
- Company No.
263321
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Apr 2015
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Adalbert Healthcare Private Limited offer?
Adalbert Healthcare Private Limited offers a wide range of products and services, including Health Conditions, Pain Relief.
Who are the key members and board of directors at Adalbert Healthcare?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Navin Kumar  | Director | 11-Jan-2019 | Current |
| Sabita Kumari | Director | 07-Apr-2022 | Current |
Financial Performance of Adalbert Healthcare.
Adalbert Healthcare Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 6.31% increase. The company also saw a substantial fall in profitability, with a 12.78% decrease in profit. The company's net worth moved up by a moderate rise of 9.82%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Adalbert Healthcare?
Unlock access to Adalbert Healthcare's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 06 Jan 2018 | ₹8.00 M | Satisfied |
How Many Employees Work at Adalbert Healthcare?
Adalbert Healthcare has a workforce of 36 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Adalbert Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Adalbert Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
